Suchergebnisse - "Con, Danny"

PubPharm (64)

1

Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B

enthalten in: Digestive diseases and sciences | 2024

von Con, D. | Tu, S. | Clayton-Chubb, D. | +4

2

Letter : Thioguanine, an under-utilised option in inflammatory bowel disease? Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Vasudevan, A. | Con, D. | van Langenberg, D.

3

Safety and effectiveness of Janus kinase inhibitors in the management of inflammatory bowel disease following liver transplantation

enthalten in: Journal of Crohn's & colitis | 2024

von Con, D. | Hilley, P. | Chin, S. | +6

4

Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B

enthalten in: Digestive diseases and sciences | 2024

von Con, D. | Tu, S. | Clayton-Chubb, D. | +4

5

Editorial : Towards optimal thiopurine therapy for inflammatory bowel disease-authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Vasudevan, A. | Con, D. | van Langenberg, D.

6

Clinical trial : Combination allopurinol-thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study)

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Vasudevan, A. | Con, D. | De Cruz, P. | +6

7

Assessing quality of magnetic resonance enterography and its impact on disease assessment of ileal Crohn's disease

enthalten in: Intestinal research | 2024

von Bohra, A. | Connoley, D. | Con, D. | +5

8

Letter : Comparing first‐line infliximab and vedolizumab for ulcerative colitis—it depends on how you use the drug

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Con, D. | Srinivasan, A.

9

Clinical trial : Combination allopurinol‐thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study)

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Vasudevan, A. | Con, D. | De Cruz, P. | +6

10

Editorial : Towards optimal thiopurine therapy for inflammatory bowel disease—authors' reply

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Vasudevan, A. | Con, D. | Langenberg, D.

1
2
3
4
5
6
7
Nächster »
[7]